Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-130230
Filing Date
2024-12-19
Accepted
2024-12-19 16:51:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9185
  Complete submission text file 0001104659-24-130230.txt   10873
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Subject) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91969 | Film No.: 241564003
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIREO HEALTH INTERNATIONAL, INC. 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address
Kingsley Kyle Eugene (Filed by) CIK: 0001836902 (see all company filings)

Type: SCHEDULE 13D/A